Similar research has also demonstrated significantly reduced CD4+, CD8+, and B lymphocyte counts in ARDS patients, along with activation of Th1 and Th2, inflammatory response cell apoptosis, cytotoxicity, and endothelial dysfunction (70, 71). Here, CD8A is linked to acute respiratory distress syndrome.